期刊
JOURNAL OF CLINICAL VIROLOGY
卷 133, 期 -, 页码 -出版社
ELSEVIER
DOI: 10.1016/j.jcv.2020.104686
关键词
SARS-CoV-2; COVID-19; Real-time RT-PCR; Viral load
类别
Introduction: Studies describing the performance characteristics of the cobas (R) 6800 system for SARS-CoV-2 detection in deep respiratory specimens and freeze-thaw stability are limited. The current study compares the clinical performance of the automated SARS-CoV-2 assay on the cobas (R) 6800 system to a lab-developed assay (LDA) and the cobas impact of freeze-thawing combined with lysis buffer. Methods: Both retrospective and prospectively selected deep respiratory samples and oroand nasopharyngeal samples in either E-swab (R) or GLYwere tested using the SARS-CoV-2 assay on the cobas (R) 6800 System and compared to a lab developed assay. Additonally, SARS-CoV-2 RNA stability was assessed after one freeze-thaw cycle with or without lysis buffer. Results: In total, 221 (58.3 %) oroand nasopharyngeal swabs, 131 (34.6 %) deep respiratory specimens, and n = 25 (6.6 %) swabs of unknown origin were included to study clinical performance. Only 4 samples gave discrepant results, all being positive in the LDA and not the cobas (R) 6800 system. For stability testing, 66 samples without and 110 with lysis buffer were included. No clinically significant difference was found in test results after one freeze-thaw cycle and addition of lysis buffer. Conclusion: Based on our findings, the cobas (R) 6800 SARS-CoV-2 RNA assay yielded similar results as the LDA in oro-/nasopharyngeal swabs and deep respiratory specimens. Moreover, the cobas (R) 6800 SARS-CoV-2 RNA assay yielded similar results before and after a freeze-thaw cycle, with better preservation of low viral loads in lysis buffer.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据